Greenlight Capital Portfolio

CIK: 0001079114 • Quarter: Q4 2023 • SEC Filing

Based on the latest 13F filing, Greenlight Capital manages a portfolio worth $2.05B, consisting of 40 securities. In the latest quarter, they added 7 new positions and exited 6 positions. The portfolio returned 11.21% this quarter and has generated a 51.97% return over the past year, outperforming the S&P 500 by 45.73%. Their average holding period is 7 quarters.

Portfolio Value

$2.05B
$287.33M (16.32%)

Portfolio Activity

40 Securities
+7 Added -6 Removed

Q4 2023 Return

$197.37M
11.21%

Holding Periods

Average 7Q
Top 10 14Q
Top 20 9Q

Historical Performance

1 Year 51.97%
3 Year 56.96%
5 Year -19477.79%

vs S&P 500

1 Year 45.73%
3 Year 48.36%
5 Year -19540.50%
New Positions
7
Increased
20
Decreased
4
Unchanged
9
Exited
6

Current Holdings

Stock
Holdings (Shares) Holdings (USD) % of Portfolio Share Count Change (Shares) Change (USD) % Change
386.94K $73.97M 3.61% Decreased -44.28K $38.73K -10.27%
2.54M $62.51M 3.05% Increased 614.49K $19.70M 31.98%
2.73M $2.79M 0.14% Increased 131.89K $-2.60M 5.07%
1.38M $19.50M 0.95% Increased 80.07K $5.21M 6.17%
Katapult Holdings
262.23K $1.94K 0.00% Unchanged - $-734 0.00%
135.61K $20.19M 0.99% Increased 7.88K $5.00M 6.17%
96.99K $1.29M 0.06% Unchanged - $-160.03K 0.00%
185.52K $17.10M 0.83% New 185.52K $17.10M 100.00%
222.97K $29.70M 1.45% Increased 12.45K $4.72M 5.91%
1.83M $18.71M 0.91% Increased 104.32K $-846.90K 6.05%
1.55M $65.61M 3.20% Increased 90.24K $2.62M 6.17%
268.47K $2.80M 0.14% New 268.47K $2.80M 100.00%
3.04M $161.07M 7.86% Decreased -99.12K $7.26M -3.15%
2.11M $211.67M 10.34% Decreased -298.55K $-40.54M -12.42%
Coya Therapeutics
1.27M $9.44M 0.46% Increased 805.96K $7.64M 172.19%
24.82K $35.22M 1.72% Increased 1.51K $3.05M 6.48%
58.54K $1.42M 0.07% Unchanged - $-99.52K 0.00%
588.41K $1.92M 0.09% Unchanged - $-8.83K 0.00%
162.58K $6.61M 0.32% Increased 6.20K $1.21M 3.96%
543.93K $25.72M 1.26% Increased 184.04K $9.60M 51.14%
6.36M $132.08M 6.45% Increased 767.94K $47.70M 13.74%
Neubase Therapeutics
136.35K $100.91K 0.00% Unchanged - $-17.68K 0.00%
34.99K $52.84K 0.00% Unchanged - $5.95K 0.00%
Nuvation BIO
100.00K $6.00K 0.00% Unchanged - $-4.00K 0.00%
554.49K $11.94M 0.58% New 554.49K $11.94M 100.00%
2.99M $30.22M 1.48% Increased 155.00K $-12.62M 5.46%
336.97K $5.68M 0.28% Unchanged - $630.13K 0.00%
Talis Biomedical
149.05K $1.11M 0.05% Unchanged - $250.41K 0.00%
1.32M $99.45M 4.86% Increased 404.19K $39.37M 44.33%
1.75M $98.42M 4.81% Increased 133.75K $23.92M 8.29%
456.61K $44.67M 2.18% Increased 26.55K $5.82M 6.17%
3.36M $36.34M 1.77% New 3.36M $36.34M 100.00%
129.67K $17.56M 0.86% New 129.67K $17.56M 100.00%
2.82M $9.80M 0.48% Increased 166.64K $1.45M 6.27%
9.27K $2.87M 0.14% Increased 2.31K $467.77K 33.19%
1.23M $63.60M 3.11% Increased 42.04K $821.66K 3.54%
250.00K $18.58M 0.91% New 250.00K $18.58M 100.00%
11.40M $592.37M 28.92% Decreased -937.50K $80.04M -7.60%
9.24M $78.83M 3.85% New 9.24M $78.83M 100.00%
3.78M $37.08M 1.81% Increased 1.76M $16.22M 86.68%

Exited Positions

Stock Previous Shares Previous Value
1.24M $25.22M
10.11M $65.18M
256.74K $24.04M
78.75K $2.38K
324.01K $5.12M
37.57K $2.10M